Verbeke C - Search Results

1

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D, Klint L, Dueland S, Lassen K; Nordic Pancreatic Cancer Trial-1 study group. Labori KJ, et al. Among authors: verbeke c. Lancet Gastroenterol Hepatol. 2024 Mar;9(3):205-217. doi: 10.1016/S2468-1253(23)00405-3. Epub 2024 Jan 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38237621 Clinical Trial.

2

Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).

Farnes I, Kleive D, Verbeke CS, Aabakken L, Issa-Epe A, Småstuen MC, Fosby BV, Dueland S, Line PD, Labori KJ. Farnes I, et al. BJS Open. 2023 Nov 1;7(6):zrad137. doi: 10.1093/bjsopen/zrad137. BJS Open. 2023. PMID: 38155512 Free PMC article.

3

Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study.

Farnes I, Lund-Iversen M, Aabakken L, Verbeke C, Labori KJ. Farnes I, et al. Among authors: verbeke c. Scand J Gastroenterol. 2024 Sep;59(9):1093-1096. doi: 10.1080/00365521.2024.2373115. Epub 2024 Jul 3. Scand J Gastroenterol. 2024. PMID: 38957079

4

Prognostic Factors for Early Recurrence After Resection of Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Leonhardt CS, Gustorff C, Klaiber U, Le Blanc S, Stamm TA, Verbeke CS, Prager GW, Strobel O. Leonhardt CS, et al. Among authors: verbeke cs. Gastroenterology. 2024 Oct;167(5):977-992. doi: 10.1053/j.gastro.2024.05.028. Epub 2024 May 31. Gastroenterology. 2024. PMID: 38825047 Free article.

5

Prognostic impact of resection margin status on survival after neoadjuvant treatment for pancreatic cancer: systematic review and meta-analysis.

Leonhardt CS, Hank T, Pils D, Gustorff C, Sahora K, Schindl M, Verbeke CS, Strobel O, Klaiber U. Leonhardt CS, et al. Among authors: verbeke cs. Int J Surg. 2024 Jan 1;110(1):453-463. doi: 10.1097/JS9.0000000000000792. Int J Surg. 2024. PMID: 38315795 Free PMC article.

6

A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer.

Löhr JM, Karimi M, Omazic B, Kartalis N, Verbeke CS, Berkenstam A, Frödin JE. Löhr JM, et al. Pancreatology. 2016 Jul-Aug;16(4):640-5. doi: 10.1016/j.pan.2016.05.002. Epub 2016 May 14. Pancreatology. 2016. PMID: 27234064 Clinical Trial.

7

Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer.

Vendittelli P, Bokhorst JM, Smeets EMM, Kryklyva V, Brosens LAA, Verbeke C, Litjens G. Vendittelli P, et al. Among authors: verbeke c. PLoS One. 2024 May 21;19(5):e0301969. doi: 10.1371/journal.pone.0301969. eCollection 2024. PLoS One. 2024. PMID: 38771787 Free PMC article.

8

The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in mice.

Fjeld K, Gravdal A, Brekke RS, Alam J, Wilhelm SJ, El Jellas K, Pettersen HN, Lin J, Solheim MH, Steine SJ, Johansson BB, Njølstad PR, Verbeke CS, Xiao X, Lowe ME, Molven A. Fjeld K, et al. Pancreatology. 2022 Dec;22(8):1099-1111. doi: 10.1016/j.pan.2022.11.003. Epub 2022 Nov 9. Pancreatology. 2022. PMID: 36379850 Free PMC article.

9

Development and external evaluation of a self-learning auto-segmentation model for Colorectal Cancer Liver Metastases Assessment (COALA).

Bereska JI, Zeeuw M, Wagenaar L, Jenssen HB, Wesdorp NJ, van der Meulen D, Bereska LF, Gavves E, Janssen BV, Besselink MG, Marquering HA, van Waesberghe JTM, Aghayan DL, Pelanis E, van den Bergh J, Nota IIM, Moos S, Kemmerich G, Syversveen T, Kolrud FK, Huiskens J, Swijnenburg RJ, Punt CJA, Stoker J, Edwin B, Fretland ÅA, Kazemier G, Verpalen IM; Pancreatobiliary and Hepatic Artificial Intelligence Research (PHAIR) consortium; Dutch Colorectal Cancer Group Liver Expert Panel. Bereska JI, et al. Insights Imaging. 2024 Nov 22;15(1):279. doi: 10.1186/s13244-024-01820-7. Insights Imaging. 2024. PMID: 39576456

10

Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer.

Amrutkar M, Guttorm SJT, Finstadsveen AV, Labori KJ, Eide L, Rootwelt H, Elgstøen KBP, Gladhaug IP, Verbeke CS. Amrutkar M, et al. Among authors: verbeke cs. Mol Oncol. 2024 Nov 15. doi: 10.1002/1878-0261.13759. Online ahead of print. Mol Oncol. 2024. PMID: 39545923 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters